相关实验视频
Updated: Jun 12, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
针对过敏疾病和喘的生物标志物驱动药物开发:FDA公开研讨会
Ronald L Rabin1, Matthew C Altman2, S Hasan Arshad3
1Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md.
The Journal of allergy and clinical immunology
|March 28, 2025
概括
过敏性喘和食物过敏药物开发的生物标志物被美国食品和药物管理局 (FDA) 讨论. 研讨会回顾了生物标志物要求和监管批准的开发状态.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学和药物开发领域
- 生物标志物研究 生物标志物研究
背景情况:
- 美国食品和药物管理局 (FDA) 于2024年2月22日召开了一场研讨会,专注于过敏性喘和食物过敏的生物标志物.
- 该活动汇集了监管机构,学者,国家卫生研究院 (NIH) 工作人员和行业代表.
- 主要讨论集中在FDA对生物标志物作为临床试验中替代终点的采用要求上.
研究的目的:
- 通知利益相关者关于FDA在药物开发中接受生物标志物的标准.
- 提供有关各种过敏疾病生物标志物的最新进展的最新信息.
- 促进关于监管前景和正在进行的研究的对话.
主要方法:
- 采用了研讨会形式,包括监管机构和调查人员的演讲.
- 讨论分为三个会议:监管观点,喘生物标志物和食物过敏生物标志物.
- 该报告总结了研讨会期间提供的信息.
主要成果:
- 研讨会澄清了FDA对利用生物标志物作为替代终点的要求.
- 介绍了许多潜在的过敏性喘和食物过敏的生物标志物的当前发展状况.
- 美国食品和药物管理局和欧盟的监管观点得到了共享.
结论:
- 研讨会强调了明确定义的生物标志物的重要性,以促进对过敏症的药物开发.
- 了解监管途径对于在临床试验中成功实施生物标志物至关重要.
- 持续的研究和合作对于验证和采用新的过敏喘和食物过敏治疗生物标志物至关重要.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
238
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
238
01:17Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
01:19Antiasthma Drugs: Leukotriene Modifiers
252
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
252
01:27Allergic Drug Reactions
818
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
818
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K